Results 211 to 220 of about 140,872 (266)

ABSTRACT 531

Pediatric Critical Care Medicine, 2014
S. Ismail, M. Kabbani
openaire   +1 more source

§ 531 Widerrufserklärung [PDF]

, 2023
openaire  

Fall 531

DMW - Deutsche Medizinische Wochenschrift, 1978
openaire   +1 more source

Supplement 531

BMJ, 1914
openaire   +1 more source

Sonderforschungsbereich 531

1997
Hans-Paul Schwefel, Ulrich Hammel
openaire   +1 more source

Pharmacodynamics and Pharmacokinetics of AMG 531, a Thrombopoiesis‐Stimulating Peptibody, in Healthy Japanese Subjects: A Randomized, Placebo‐Controlled Study

Journal of Clinical Pharmacology, 2007
Yuji Kumagai, Masayuki Ohkura, J L Nichol   +2 more
exaly  

Animal experiments on the compensation of the immunosuppressive action of cyclophosphamide by 2-[-2-cyanaziridinyl-(1)-]-2-[-2-carbamoylaziridinyl-(l)]-propane BM 12 531

Experimentelle Pathologie, 1978
U Bicker
exaly  

Pharmacology of the Thromboxane Receptor Antagonist and Thromboxane Synthase Inhibitor BM‐531

Cardiovascular Drug Reviews, 2001
Stephanie Rolin, Xavier Leval, Jacques Delarge   +2 more
exaly  

An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura

British Journal of Haematology, 2006
Adrian Newland, F Lefrere, Jaap Jan Zwaginga   +2 more
exaly  

Influence of the immunomodulating compound BM 12.531 (azimexone) on radioresistance and granulopoietic colony forming units in mice

Experimental Pathology, 1981
W D Gassel, U Bicker
exaly